<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02105610</url>
  </required_header>
  <id_info>
    <org_study_id>VOLATILE/38/OSR</org_study_id>
    <nct_id>NCT02105610</nct_id>
  </id_info>
  <brief_title>Volatile Anesthetics to Reduce Mortality in Cardiac Surgery</brief_title>
  <acronym>MYRIAD</acronym>
  <official_title>Volatile Anesthetics to Reduce Mortality in Cardiac Surgery: A Multicentre Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università Vita-Salute San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università Vita-Salute San Raffaele</source>
  <brief_summary>
    <textblock>
      There is initial evidence that the choice of anesthesia can influence survival in the
      specific setting of coronary artery bypass grafting surgery (CABG).

      A recent international consensus conference included volatile agents among the few
      drugs/techniques/strategies that might reduce perioperative mortality in cardiac surgery and
      that should be further studied. Volatile anesthetics (desflurane, isoflurane and sevoflurane)
      have non-anesthetic pharmacological characteristics that confer cardiac protection when
      compared to Total IntraVenous Anesthesia (TIVA). Several randomized controlled studies were
      summarized in a meta-analysis that documented a reduction in perioperative cardiac troponin
      release and mortality in patients receiving volatile anesthetics when compared to patients
      receiving a TIVA. There are four published studies (Bignami et al. 2009) (De Hert et al.
      2009) (Jackobsen et al. 2007) (Landoni et al. 2007) suggesting that these benefits can
      translate into a reduced mortality rate in patients receiving volatile agents. The level of
      evidence for these four studies is not high (one meta-regression, one underpowered randomized
      controlled study, one retrospective study and one meta-analysis of small randomized studies)
      and there is need for a large multicentre randomized controlled study to confirm these
      findings, as suggested by the international consensus conference on this topic published in
      2011 (Landoni et al 2011).

      The purpose is to provide a large multicentre controlled randomized trial to demonstrate that
      volatile anesthetics can reduce 1 year mortality from 3% to 2% in patients undergoing CABG
      (either with or without cardiopulmonary bypass).

      The results of this study can support the use of volatile agents in all CABG procedures
      worldwide (more than 500.000 per year) with 2.500 lives saved per year (in the hypothesis
      that nowadays half the procedures are performed with a TIVA and that 1 year mortality can be
      reduced from 3% to 2% using volatile agents).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5400</enrollment>
  <condition>Aortocoronary Bypass</condition>
  <condition>Cardiac Surgery</condition>
  <condition>Coronary Artery Bypass Grafting</condition>
  <arm_group>
    <arm_group_label>volatile anesthetics (desflurane, isoflurane, sevoflurane)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>total intravenous anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>desflurane, isoflurane, sevoflurane</intervention_name>
    <arm_group_label>volatile anesthetics (desflurane, isoflurane, sevoflurane)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>total intravenous anesthetics</intervention_name>
    <arm_group_label>total intravenous anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;18 years

          -  written informed consent

          -  scheduled procedures

          -  planned isolated CABG (multiple bypass are allowed; planned combined intervention such
             as CABG plus valve surgery are not allowed

        Exclusion Criteria:

          -  pregnancy

          -  planned valve surgery or surgery on the aorta

          -  planned locoregional anesthesia without general anesthesia

          -  unstable or ongoing angina

          -  recent (&lt; 1 month) or ongoing acute myocardial infarction

          -  use of sulfonylurea, theophylline or allopurinol

          -  previous unusual response to an anesthetic agent

          -  inclusion in other randomised controlled studies in the previous 30 days

          -  any general anesthesia performed in the previous 30 days

          -  emergency operation (not scheduled)

          -  Kidney or liver transplant in medical history

          -  Liver cirrhosis (Child B or C)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>alberto zangrillo, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Vita-Salute University of Milano</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mohammed Bin Khalifa Bin Sulman Al-Khalifa Cardiac Center - Bahrain</name>
      <address>
        <city>Bahrain</city>
        <country>Bahrain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital das Clínicas da Faculdade de Medicina da USP - Istituto do Coracao</name>
      <address>
        <city>Sao Paulo</city>
        <state>Barazil</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dante Pazzanese Institute of Cardiology</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Center Pontica</name>
      <address>
        <city>Burgas</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Dubrava</name>
      <address>
        <city>Dubrava</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General University Hospital, Charles University</name>
      <address>
        <city>Prague</city>
        <state>Czech Republic</state>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Clinical and Experimental Medicine</name>
      <address>
        <city>Prague</city>
        <state>Czech Republic</state>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mansoura University hospitals</name>
      <address>
        <city>Egypt</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Faculty of Medicine - Zagazig University</name>
      <address>
        <city>Zagazig</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario Magna Graecia</name>
      <address>
        <city>Catanzaro</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele di Milano, Italy</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera San Camillo-Forlanini</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Malaya Medical Centre</name>
      <address>
        <city>Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Maria</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federal Centre for Cardiac Surgery</name>
      <address>
        <city>Astrakhan</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ural Institute of Cardiology</name>
      <address>
        <city>Ekaterinburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scientific Research Institute for Complex Issues of Cardiovascular Disease</name>
      <address>
        <city>Kemerovo</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moscow Clinical Regional Research Institute</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Negovskiy Reanimatology Research Institute</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Research Institute of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federal Almazov Medical Research Centre</name>
      <address>
        <city>Saint Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiovascular Diseases &quot;Dedinje&quot;</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bahrain</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Croatia</country>
    <country>Czechia</country>
    <country>Egypt</country>
    <country>Italy</country>
    <country>Malaysia</country>
    <country>Portugal</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <link>
    <url>http://www.unisr.it/persona.asp?id=8713&amp;linguacv=english</url>
    <description>CV Prof Landoni</description>
  </link>
  <reference>
    <citation>Landoni G, Greco T, Biondi-Zoccai G, Nigro Neto C, Febres D, Pintaudi M, Pasin L, Cabrini L, Finco G, Zangrillo A. Anaesthetic drugs and survival: a Bayesian network meta-analysis of randomized trials in cardiac surgery. Br J Anaesth. 2013 Dec;111(6):886-96. doi: 10.1093/bja/aet231. Epub 2013 Jul 12.</citation>
    <PMID>23852263</PMID>
  </reference>
  <reference>
    <citation>Landoni G, Rodseth RN, Santini F, Ponschab M, Ruggeri L, Székely A, Pasero D, Augoustides JG, Del Sarto PA, Krzych LJ, Corcione A, Slullitel A, Cabrini L, Le Manach Y, Almeida RM, Bignami E, Biondi-Zoccai G, Bove T, Caramelli F, Cariello C, Carpanese A, Clarizia L, Comis M, Conte M, Covello RD, De Santis V, Feltracco P, Giordano G, Pittarello D, Gottin L, Guarracino F, Morelli A, Musu M, Pala G, Pasin L, Pezzoli I, Paternoster G, Remedi R, Roasio A, Zucchetti M, Petrini F, Finco G, Ranieri M, Zangrillo A. Randomized evidence for reduction of perioperative mortality. J Cardiothorac Vasc Anesth. 2012 Oct;26(5):764-72. doi: 10.1053/j.jvca.2012.04.018. Epub 2012 Jun 20. Review.</citation>
    <PMID>22726656</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2014</study_first_submitted>
  <study_first_submitted_qc>April 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2014</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università Vita-Salute San Raffaele</investigator_affiliation>
    <investigator_full_name>Giovanni Landoni</investigator_full_name>
    <investigator_title>MD, Associate Professor</investigator_title>
  </responsible_party>
  <keyword>volatile anesthetics</keyword>
  <keyword>desflurane</keyword>
  <keyword>isoflurane</keyword>
  <keyword>sevoflurane</keyword>
  <keyword>TIVA</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>mortality</keyword>
  <keyword>anesthesia</keyword>
  <keyword>intensive care</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Anesthetics, Intravenous</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

